Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | dopamine receptor D2 | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled | Starlite/ChEMBL | References |
Rattus norvegicus | Serotonin 2a (5-HT2a) receptor | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled | Starlite/ChEMBL | References |
Homo sapiens | potassium voltage-gated channel, subfamily H (eag-related), member 2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | g protein coupled receptor | Serotonin 2a (5-HT2a) receptor | 471 aa | 416 aa | 19.2 % |
Schistosoma japonicum | ko:K04136 adrenergic receptor, alpha 1b, putative | Serotonin 2a (5-HT2a) receptor | 471 aa | 422 aa | 27.5 % |
Echinococcus multilocularis | g protein coupled receptor | Serotonin 2a (5-HT2a) receptor | 471 aa | 462 aa | 21.2 % |
Echinococcus multilocularis | g protein coupled receptor | Serotonin 2a (5-HT2a) receptor | 471 aa | 417 aa | 20.6 % |
Echinococcus granulosus | g protein coupled receptor | Serotonin 2a (5-HT2a) receptor | 471 aa | 408 aa | 21.8 % |
Schistosoma japonicum | ko:K04209 neuropeptide Y receptor, invertebrate, putative | Serotonin 2a (5-HT2a) receptor | 471 aa | 405 aa | 25.4 % |
Onchocerca volvulus | Ubiquinol-cytochrome-c reductase complex assembly factor 1 homolog | Serotonin 2a (5-HT2a) receptor | 471 aa | 435 aa | 23.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0042 | 0.0042 | 0.5 |
Echinococcus multilocularis | serotonin receptor | 0.015 | 0.1569 | 1 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0042 | 0.0042 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.015 | 0.1569 | 0.1569 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.015 | 0.1569 | 1 |
Leishmania major | C-8 sterol isomerase-like protein | 0.0747 | 1 | 1 |
Echinococcus multilocularis | serotonin receptor | 0.015 | 0.1569 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0747 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0382 | 0.4844 | 0.4844 |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.0747 | 1 | 1 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.0747 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.015 | 0.1569 | 0.1569 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.015 | 0.1569 | 1 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0045 | 0.0083 | 0.0083 |
Brugia malayi | Serotonin receptor | 0.0587 | 0.7748 | 0.7729 |
Onchocerca volvulus | 0.0279 | 0.3393 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 98 % | In vivo occupancy at rat 5-HT2A receptor at 30 min after dosing at 10 mg/kg per orally | ChEMBL. | 15993598 |
Activity (functional) | = 98 % | In vivo occupancy at rat 5-HT2A receptor at 30 min after dosing at 10 mg/kg per orally | ChEMBL. | 15993598 |
Clp (ADMET) | = 69 ml min-1 | Plasma clearence of the compound after i.v. administration in rat | ChEMBL. | 15993598 |
F (ADMET) | = 51 % | Bioavailability in rat | ChEMBL. | 15993598 |
Ki (binding) | = 0.39 nM | Binding affinity against human 5-hydroxytryptamine 2A receptor | ChEMBL. | 15993598 |
Ki (binding) | = 0.39 nM | Displacement of [3H]ketanserin from human 5HT2A receptor expressed in CHO cells | ChEMBL. | 17314044 |
Ki (binding) | = 0.39 nM | Binding affinity against human 5-hydroxytryptamine 2A receptor | ChEMBL. | 15993598 |
Ki (binding) | = 0.39 nM | Displacement of [3H]ketanserin from human 5HT2A receptor expressed in CHO cells | ChEMBL. | 17314044 |
Ki (binding) | = 0.39 nM | Displacement of [3H]- ketanserin from human 5HT2A receptor expressed CHO cells | ChEMBL. | 20493697 |
Ki (binding) | = 0.63 nM | Binding affinity against rat 5-hydroxytryptamine 2A receptor | ChEMBL. | 15993598 |
Ki (binding) | = 0.63 nM | Binding affinity against rat 5-hydroxytryptamine 2A receptor | ChEMBL. | 15993598 |
Ki (binding) | = 69 nM | Displacement of [3H]mesulergine from human 5HT2C receptor expressed CHO cells | ChEMBL. | 20493697 |
Ki (binding) | = 176 nM | Binding affinity against human 5-hydroxytryptamine 2c receptor | ChEMBL. | 15993598 |
Ki (binding) | = 176 nM | Binding affinity against human 5-hydroxytryptamine 2c receptor | ChEMBL. | 15993598 |
Ki (binding) | = 180 nM | Displacement of [3H]mesurgeline from human 5HT2C receptor expressed in CHO cells | ChEMBL. | 17314044 |
Ki (binding) | = 180 nM | Displacement of [3H]mesurgeline from human 5HT2C receptor expressed in CHO cells | ChEMBL. | 17314044 |
Ki (binding) | = 310 nM | Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells | ChEMBL. | 17314044 |
Ki (binding) | = 310 nM | Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells | ChEMBL. | 17314044 |
Ki (binding) | = 313 nM | Binding affinity against human Dopamine receptor D2 | ChEMBL. | 15993598 |
Ki (binding) | = 313 nM | Binding affinity against human Dopamine receptor D2 | ChEMBL. | 15993598 |
Ki (binding) | = 5561 nM | Binding affinity against human IKr channel | ChEMBL. | 15993598 |
Ki (binding) | = 5561 nM | Binding affinity against human IKr channel | ChEMBL. | 15993598 |
Ki (binding) | = 5561 nM | Displacement of [3H]-dofetilide from human ERG receptor expressed HEK cells | ChEMBL. | 20493697 |
Ki (binding) | = 5600 nM | Displacement of [3H]dofetilide from hERG expressed in HEK cells | ChEMBL. | 17314044 |
Ki (binding) | = 5600 nM | Displacement of [3H]dofetilide from hERG expressed in HEK cells | ChEMBL. | 17314044 |
pKa | = 6.3 | pKa value of the compound | ChEMBL. | 15993598 |
Ratio Ki (binding) | = 460 | Selectivity for human 5HT2A receptor over human 5HT2C receptor | ChEMBL. | 17314044 |
T1/2 (ADMET) | = 3.8 hr | Half life period of the compound was determined | ChEMBL. | 15993598 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
3 literature references were collected for this gene.